Modeling and Simulation - PK/PD Archives | Page 23 of 47 | Certara

Publication

Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications

CertaraMay 1, 2017

Publication

Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats

CertaraMay 1, 2017

Publication

Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation

CertaraApril 1, 2017

Blog

The Model-informed Precision Dosing Revolution Is Coming

Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…

CertaraMarch 7, 2017

Publication

CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites

CertaraMarch 1, 2017

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

CertaraJanuary 10, 2017

Publication

Clarification of Contraceptive Drug Pharmacokinetics in Obesity

CertaraJanuary 1, 2017

Publication

Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer

CertaraDecember 18, 2016

Brochure

Phoenix IVIVC Toolkit

Explore the comprehensive features of the IVIVC Toolkit.

CertaraDecember 14, 2016

Publication

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy

CertaraDecember 5, 2016

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy